Onesource Specialty Pharma Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting
11-11-2025 | 06:11 pm
11-11-2025 | 06:11 pm
OneSource Specialty Pharma's board approved Q2 & H1 financial results. Consolidated Q2 revenue reached ₹375.76 Cr with ₹10.49 Cr profit. A major merger scheme to absorb several subsidiaries and undertake financial restructuring also received board approval.
No comments yet. Be the first to comment!
